Literature DB >> 9481036

New trends in antimicrobial development.

E L Setti1, R G Micetich.   

Abstract

The continual evolution of microbial resistance to the available classes of antibiotics poses a serious threat to the efficacy of traditional antibacterial therapy. Today, there are two main approaches that are being applied to discover better and more effective anti-infective agents against common as well as resistant pathogens: (a) the improvement of the "classical" antimicrobial agents by targeting the so called "resistance factors", and (b) the search of new anti-infective agents with novel modes of actions. This review will highlight the most relevant aspects of both of these approaches and some of the latest findings in the field of antimicrobial discovery.

Mesh:

Substances:

Year:  1998        PMID: 9481036

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  NMR-restrained docking of a peptidic inhibitor to the N-terminal domain of the phosphoenolpyruvate:sugar phosphotransferase enzyme I.

Authors:  D Rognan; S Mukhija; G Folkers; O Zerbe
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

2.  Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri.

Authors:  Anthony A Emanuele; Nancy E Adams; Yi-Chen Chen; Anthony T Maurelli; George A Garcia
Journal:  J Antibiot (Tokyo)       Date:  2014-02-19       Impact factor: 2.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.